Sofosbuvir and Ledipasvir, a new COMBO Hepatitis C treatment

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.

HCV Advocate in the USA has just published an excellent fact sheet on the new hepatitis C combo from Gilead, sofosbuvir (SOVALDI) and ledipasvir for genotype 1 only.  Note ledipasvir alone, or in this or any other combination, is still unavailable in Canada, except in an approved clinical trial. Read factsheet:
http://www.hcvadvocate.org/hepatitis/factsheets_pdf/Phase_3_Genotype_1_SOF-LDV.pdf

Leave a Reply